Skip to main content

Published locations for Tocilizumab (Actemra) scores FDA approval for systemic sclerosis–associated interstitial lung disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Tocilizumab (Actemra) scores FDA approval for systemic sclerosis–associated interstitial lung disease

User login

  • Reset your password
  • /content/tocilizumab-actemra-scores-fda-approval-systemic-sclerosis-associated-interstitial-lung
  • /internalmedicinenews/article/236794/lupus-connective-tissue-diseases/tocilizumab-actemra-scores-fda
  • /rheumatologynews/article/236794/lupus-connective-tissue-diseases/tocilizumab-actemra-scores-fda
  • /pulmonary-health-hub/article/236794/lupus-connective-tissue-diseases/tocilizumab-actemra-scores-fda
  • /jcomjournal/article/236794/lupus-connective-tissue-diseases/tocilizumab-actemra-scores-fda-approval
  • /rheumatology/article/236794/lupus-connective-tissue-diseases/tocilizumab-actemra-scores-fda-approval
  • /internalmedicine/article/236794/lupus-connective-tissue-diseases/tocilizumab-actemra-scores-fda
  • /chestphysician/article/236794/lupus-connective-tissue-diseases/tocilizumab-actemra-scores-fda